The Clear + Brilliant, which previously received CE mark, is based on fractional laser technology that is performed in a professional setting.
The launch of Clear + Brilliant laser aesthetic treatments is designed to attract younger patients looking to take control of their aging process.
Solta Medical’s other products include Thermage, Fraxel, Isolaz, and CLARO.
Solta Medical president and CEO Stephen Fanning said with the FDA clearance of their Clear + Brilliant system, they are strengthening their product portfolio and meeting the needs of skin care professionals and their patients.
The company began shipping the product to customers in certain international markets in April and plans to begin shipments domestically later this month.
The Clear + Brilliant laser aesthetic treatment will be launched at the World Congress of Dermatology in Seoul, Korea on 25 May 2011.
